Plain-English translation of NCT05572229 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a medication called , when combined with either or , can safely help older adults with newly diagnosed multiple myeloma achieve very good responses to treatment. Multiple myeloma is a cancer of plasma cells in the bone marrow, and this trial is exploring whether these new combination approaches work better than existing options for patients over 65 who cannot undergo stem cell transplant.
Doctors need better treatment options for older patients with newly diagnosed multiple myeloma who cannot receive stem cell transplants. This trial aims to see whether combining this medication with other approved treatments can produce strong responses while remaining safe and manageable for elderly patients.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive one of two combination treatments: either with , or with . You will take or receive these medications according to a treatment schedule at a participating medical center. You will continue treatment until your cancer stops responding or you experience unacceptable side effects. Throughout the trial, you will have regular visits for blood tests, physical exams, and disease monitoring to track how well the treatment is working and to watch for any safety concerns.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France